<div id = "firstBodyDiv" data-bind-html-content-type = "article" data-bind-html-compile = "article.body" data-first-article-body = "
In light of the suffering of many countries from the spread Corona Virus, The interest in a drug Remdisiver Significant, as there are currently no approved treatments or vaccines for Covid-19 disease, which is a respiratory disorder caused by novel coronavirus.
And company got Gilliad Last week on approval US FDA On the urgent use of the drug Remediesiver as a treatment for Covid-19 after the company provided data showing that the drug helped people with the disease.
The company stated, Tuesday, that it is negotiating long-term licenses with a number of pharmaceutical companies in India AndPakistan To produce a remdeciver for developing countries and it will provide technology to assist in production.
Reuters quoted a senior official of Beximco Pharmaceuticals, one of the major drug makers in Bangladesh, as saying that the company would start production of Remisdiver this month.
Gilliad said she would donate the first million and a half doses of the drug and that it was focusing on making the drug available at an affordable price to as many people as possible after approval.
She added that she is working to establish a consortium with a number of partners to maximize the global supply of the property, and the production of the property needs rare raw materials and special manufacturing capabilities.
The company also said that it is in an advanced stage of talks with the United Nations Children’s Fund (UNICEF) to deliver the drug using the organization’s distribution networks.
“>
In light of the suffering of many countries from the spread Corona Virus, The interest in a drug Remdisiver Significant, as there are currently no approved treatments or vaccines for Covid-19 disease, which is a respiratory disorder caused by novel coronavirus.
And company got Gilliad Last week on approval US FDA On the urgent use of the drug Remediesiver as a treatment for Covid-19 after the company provided data showing that the drug helped people with the disease.
The company stated, Tuesday, that it is negotiating long-term licenses with a number of pharmaceutical companies in India AndPakistan To produce a remdeciver for developing countries and it will provide technology to assist in production.
Reuters quoted a senior official of Beximco Pharmaceuticals, one of the major drug makers in Bangladesh, as saying that the company would start production of Remisdiver this month.
Gilliad said she would donate the first million and a half doses of the drug and that it was focusing on making the drug available at an affordable price to as many people as possible after approval.
She added that she is working to establish a consortium with a number of partners to maximize the global supply of the property, and the production of the property needs rare raw materials and special manufacturing capabilities.
The company also said that it is in an advanced stage of talks with the United Nations Children’s Fund (UNICEF) to deliver the drug using the organization’s distribution networks.
– .
